Bayshore Pharmaceuticals recalls
1 recall filed under Bayshore Pharmaceuticals. The most recent was published August 19, 2020.
-
Elevated risk · 6+ years ago
Bayshore Pharmaceuticals Metformin Hydrochloride Extended-Release Tablets USP recall: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
About this page
Bayshore Pharmaceuticals appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.